The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Chadwick Jeremy G since 2009.
This trader's CIK number is 1388406.
At the time of last reporting, Chadwick Jeremy G was the Chief Operating Officer of Kymera Therapeutics, Inc.. (stock ticker symbol KYMR).
Also see all insider trading activities at Kymera Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2009 | SNTA | 0 | $0 | 4,573 | $28,370 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | KYMR | 0 | $0 | 1,383 | $42,411 | 0 | $0 |
2024 | KYMR | 0 | $0 | 2,575 | $90,104 | 0 | $0 |
1. Madrigal Pharmaceuticals, Inc. (SNTA)
2. Kymera Therapeutics, Inc. (KYMR)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2009-01-05 | SNTA | Sale | 4,573 | 6.20 | 28,370 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-03-03 | KYMR | Sale | 1,383 | 30.67 | 42,411 |
2024-05-23 | KYMR | Sale | 2,575 | 34.99 | 90,104 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Chadwick Jeremy G (Chief Operating Officer of Kymera Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.